Teva Stands By Orange Book Listings As FTC Takes Further Action
Firm Responds To Reports Of FTC Investigation Over Inhaler Patents, After Refusal To Delist
• By David Wallace
Teva says its patents are properly listed in the FDA’s Orange Book • Source: Shutterstock 
